Category:Christopher DAVIES

Christopher DAVIES

Executive Summary

Christopher DAVIES is an inventor who has filed 1 patents. Their primary areas of innovation include {Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors} (1 patents), Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers (1 patents), Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers (1 patents), and they have worked with companies such as Evox Therapeutics Limited (1 patents). Their most frequent collaborators include (1 collaborations), (1 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• A61K47/6901 ({Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors}): 1 patents
• A61K47/64 (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers): 1 patents
• A61K47/643 (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers): 1 patents
• C12N5/0662 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12P21/02 (having a known sequence of two or more amino acids, e.g. glutathione): 1 patents

Companies

List of Companies

• Evox Therapeutics Limited: 1 patents

Collaborators

• Justin HEAN (1 collaborations)
• Xiuming LIANG (1 collaborations)